
--- Page 1 ---
FiNAL DIAGNOSIS: Part 1: Lymph node, right axillary, sentinel. node number 1, sentinel node biopsy -. ONE LymPh nODE POSITiVE fOR mETASTaTIC CARcinOmA (1/1). Part 2: Lymph nODe, RIght AXIlLARy, SentiNeL nODe NumBer 2, Sentinel nOde BiOpSy - One Lymph nOde pOsitIve fOR metastatic CARcinomA (1/1). Part 3: Lymph node, right axillary, nonsentinel, Lymph node biopsy -- TWO Lymph NODes nEgAtive fOR metAStATiC CArcinOma (0/2). Part 4: Lymph node, right axillary, Sentinel node number 3, sentinel node biopsy - 1cs-0-3  One Lymph nODe pOsitive for micrOmetastatic CArcinoma (1/1). Chrtnoma infi/trstg cluct,n0s 8560/3 Part 5: breast. Right, Segmental mastectomy - Sits:buest,Nos C5O.9 3f13/u p A.  Infiltrating Ductal Carcinqma. B. nOtTinghAm'ScORe 4/9, grAbe 1 (tuBuLes 2, nucleI 1, mitOses 1). C.  NEOPLASM mEASURES 2.8 CM iN mAXImUm DimENSION (see comment). D.  NO LYMPHOVASCULAR INVASION IDENTIFIED. E.  NEOPLASM EXTENDS FOCALLY TO POSTERIOR MARGIN OF RESECTION IN THE INFERIOR ASPECT (BLOCK 5J), ALL Other mArgins Of ReSectiOn free Of neOpLASm. F Er positive, pr negative, her-2/neu negative per previous report. G. Pathologic Stage: pt2, pN1, pMX. H. DUCTAL CARCINOMA IN SITU, CRIBRIFORm AND MICROPAPILLARy TYPES, NUCLEAR GRADE 1 WITH ASSOCIATED MICROCALCIFICATIONS AND FOCAL COMEDONECROSIS. I. in SiTU COMpONeNt IS ADMIXED WITh INVASIVE COMpONenT AND IS IDEnTIFIeD iN EIght BLOCKS (THrEE COnSEcuTIVE SLiCEs mEASURING APPROxImATeLy 1.2 Cm). J. MArGiNs Of RESEctiOn frEe Of in Situ COmpOnent, CLOseSt iNferiOR at 0.3 Cm. K. Atypical Ductal hyperplaSiA. FAT NECROSIS AND REPARATIVE CHANGES ASSOCIATED WITH PREVIOUS BIOPSY. M. FIBrROCySTIc CHAnges WITh SCLerOsing ADenOSIS, DUctAL EPitheLiAL hypERPLASIA, FIBROADENOMATOUS NODULE AND EPITHELIUM ASSOCIATED CALCIFICATIONS. Part 6: Lymph nodes, Right AxilLary, AxilLary Dissection -  Nineteen Lymph noDes negative for metastatIc Carcinoma (0/19). CASE SYNOPSIS:  SynOpTiC - PRImARy INVASIVE CARCinOmA Of bREASt LAtEraLITy: PRoceDUre: Right LOCATION: Segmental Not specified SIZE OF TUMOR:  Maximum dimension invasive component: 2.8 cm  MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): No NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS Nuclear grade: 1 Tubule formation: 2 UUID:7F75F15A-2476-4FFD-97B3-313F06568E21 Mitotic activity score: 1 TCGA-BH-A0BM-01A-PR Redacted Total Nottingham score: 4 Nottingham grade (1, 2, 3): 1 ANGIOLYMPHATIC INVASION: No DERmAL LyMPHATIC INVASION: CALCIFICATION: Not applicable Yes, benign zones Yes, malignant zones TumOr TYpe, iN SITu: Cribriform Micropapillary DCIS admixed with invasive carcinoma  Percent of tumor occupied by in situ component: 5 % SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: Yes, focal No Distance of in situ disease to closest margin: 3 mm LymPH nODES POSITiVE: LYMPH NODES EXAMINED: 3  METHOD(S) OF LYMPH NODE EXAMiNATION: 24 H/E stain, Keratin stain SENTINEL NODE METASTASIS: Yes ONLy KERATIN POSITIVE CELLS ARE PRESEnT: SIZE OF NODAL METASTASES: No Diameter of largest lymph node metastasis: 25.0 mm LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: NON-NEOPLASTIC BREAST TISSUE: ADH, FCD No t stage, pathologic: pT2 N stage, pathologic: m stage, pathologic: pN1a ESTROGEN RECEPTORS: pMX  positive PROGESTERONE RECEPTORS: negative HER2/NEU: zero or 1+